Account Options

  1. Sign in
The old Google Groups will be going away soon.
Switch to the new Google Groups.
Google Groups Home
« Groups Home
ARC1779 for TTP
There are currently too many topics in this group that display first. To make this topic appear first, remove this option from another topic.
There was an error processing your request. Please try again.
flag
  3 messages - Collapse all  -  Translate all to Translated (View all originals)
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post will appear after it is approved by moderators
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
skharoon  
View profile  
 More options Sep 9 2008, 1:49 am
From: skharoon <skhar...@gmail.com>
Date: Mon, 8 Sep 2008 22:49:48 -0700 (PDT)
Local: Tues, Sep 9 2008 1:49 am
Subject: ARC1779 for TTP
Hi,

I have found one article on internet drug for TTP.

Has any one knows about this....

Pls reply.....

--------------------------------------------------------------------------- ----------------------------------

ARC1779 for TTP

ARC1779 is currently in Phase 2 clinical development with a clinical
trial designed to assess the safety, pharmacokinetics and
pharmacodynamic effects of ARC1779 in approximately 28 patients with
vWF-mediated platelet function disorders, including acute TTP.
Archemix expects this trial to conclude in 3Q 2008.

http://www.archemix.com/website/index.php
http://www.archemix.com/website/products_1779_ttp.php

Archemix’ ARC1779 Granted Orphan Designation in EU for the Treatment
of
TTP, a Life-Threatening Blood Disorder
http://www.archemix.com/website/_popup_press_release.php?release=49

Archemix’ ARC1779 Granted Orphan Designation for the Treatment of TTP,
a
Life-Threatening Blood Disorder
http://www.archemix.com/website/_popup_press_release.php?release=48

Archemix Announces Initiation of Phase 2 Trial for Aptamer Product
Candidate ARC1779 in Patients with TTP, a Rare, Life-Threatening Blood
Disorder
http://www.archemix.com/website/_popup_press_release.php?release=47

Product Pipeline
http://www.archemix.com/website/products.php

--------------------------------------------------------------------------- ----------------------------------


 
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
i...@congenitalttp.com  
View profile  
 More options Sep 9 2008, 8:53 am
From: i...@congenitalttp.com
Date: Tue, 9 Sep 2008 05:53:22 -0700 (PDT)
Local: Tues, Sep 9 2008 8:53 am
Subject: Re: ARC1779 for TTP
Thank you for the information.  I am going to check with our
Hemetologist.

On Sep 9, 12:49 am, skharoon <skhar...@gmail.com> wrote:


 
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
Juan Lo  
View profile  
 More options Sep 10 2008, 10:48 am
From: "Juan Lo" <juaninmiam...@gmail.com>
Date: Wed, 10 Sep 2008 10:48:48 -0400
Local: Wed, Sep 10 2008 10:48 am
Subject: Re: ARC1779 for TTP

This is the first I hear of this.  Looks promising.


 
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
End of messages
« Back to Discussions « Newer topic     Older topic »